An interventional study of Calcium in Nutritional and Metabolic Diseases, sponsored by Northumbria University. Completed at 1 site in United Kingdom. Open to male participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-09-11.
Sponsored by Northumbria University · Not applicable, Interventional, and Basic science
The purpose of this study is to investigate the appetite, insulin and incretin hormone responses to a high-calcium meal.
Participants will be provided with control and high-calcium meals. Insulin, appetite, glucagon-like peptide-1 and glucose-dependent insulinotropic peptide responses will be assessed, along with rates of substrate oxidation.
997 studies on the registry are indexed under Metabolic Diseases; 234 are open to participants now.
This study's enrollment of 10 is below the median of 48 across 670 interventional studies indexed under Metabolic Diseases.
Browse Metabolic Diseases studies →Northumbria University is the lead sponsor of 156 studies on the registry; 22 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Breakfast consisting of milk-based porridge with a normal calcium content.
As control, but with a high-calcium content.
Dietary Supplement: Calcium
Milk-calcium supplement
Subjective appetite ratings
Subjective ratings of appetite assessed by visual analogue scales.
Time frame: 3 hour
Serum insulin concentration
2 hour area under the curve for serum insulin following breakfast consumption
Time frame: 2 hour
Plasma glucose-dependent insulinotropic peptide concentration
2 hour area under the curve for plasma glucose-dependent insulinotropic peptide following breakfast consumption
Time frame: 2 hour
Plasma glucagon-like peptide-1 concentration
2 hour area under the curve for plasma glucagon-like peptide-1 following breakfast consumption
Time frame: 2 hour
Total fat oxidised during 60 min of exercise (g)
Assessed by indirect calorimetry
Time frame: 1 hour
This study is completed, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Northumbria University